On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Series A – Dunad Therapeutics
On Nov 2, 2021 Dunad Therapeutics closed a Series A round and raised $24,000,000 from BioGeneration Ventures, Epidarex Capital, Novartis, featuring lead investors BioGeneration Ventures. […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Series A – Aktiia
On Nov 2, 2021 Aktiia closed a Series A round and raised $17,500,000 from 415 CAPITAL, Draper Esprit, Redalpine, Translink Capital, Verve Ventures, featuring lead […]
Series B – United Dental
On Nov 2, 2021 United Dental closed a Series B round and raised $5,000,000 from High Speed Ventures, featuring lead investors High Speed Ventures. About […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
Series B – New View Surgical
On Nov 2, 2021 New View Surgical closed a Series B round and raised $9,000,000 from Ariel Savannah Angel Partners, Charleston Angel Partners, Corza Medical, […]
Series B – Violet Defense
On Nov 2, 2021 Violet Defense closed a Series B round and raised $20,000,000 from Katalyst Securities, Kirenaga Partners, featuring lead investors Katalyst Securities, Kirenaga […]
Series B – Hopstem
On Oct 31, 2021 Hopstem closed a Series B round and raised $40,000,000 from BioVenture, Lilly Asia Ventures, featuring lead investors . About the company: […]
Series B – Hopstem
On Oct 31, 2021 Hopstem closed a Series B round and raised $40,000,000 from BioVenture, Lilly Asia Ventures, featuring lead investors . About the company: […]
